PLGA/TPGS nanoparticles for docetaxel delivery: The pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cells
Main Author: | |
---|---|
Publication Date: | 2025 |
Other Authors: | , , , , , , , , , |
Format: | Article |
Language: | eng |
Source: | Repositório Institucional da UNESP |
Download full: | http://dx.doi.org/10.1016/j.xphs.2025.103766 https://hdl.handle.net/11449/299532 |
Summary: | Prostate cancer is the most common malignancy in men worldwide and docetaxel (DTX) is the treatment of choice. However, both the drug and formulation excipients for drug solubilization can cause side effects. In this context, the development of polymeric nanoparticles offers advantages to improve drug delivery and reduce toxicity. In the present work, factorial design was used to evaluate the effect of the amount of poly(L-lactide-co-glycolide) (PLGA) or poly(L-lactide-co-glycolide acid-polyethylene glycol) (PLGA-PEG), D-Alpha-Tocopheryl Polyethylene Glycol Succinate (TPGS) and ratio between aqueous and oily phases on the nanoparticle characteristics. The nanocarriers were characterized regarding particle size, polydispersity, zeta potential, DTX encapsulation efficiency, morphology by transmission electron microscopy, DSC, TGA and FTIR. It was evaluated in vitro for cytotoxicity and cellular uptake in prostate cancer cells. Pegylated nanoparticles, which have a different composition (TPGS%, AP:OP ratio), reduced the nanoparticle size to 105.97 ± 5.16 nm, in PDI 0.13 ± 0.03, zeta potential of -34.73 ± 1.19 mV and increased the encapsulation efficiency to 96.78 ± 1.20%. Characterization by DSC, TGA and FTIR confirmed drug encapsulation and showed colloidal stability. Pegylated nanoparticles were more stable upon serum incubation and adsorbed less proteins. In conclusion, the pegylation of the nanoparticles affected the physicochemical parameters. Also, the pegylation of nanoparticles decreased uptake by macrophages. Finally, cellular uptake and cell cytotoxicity were higher in tumor cells when compared to non-tumor cells, although they were not affected by pegylation. |
id |
UNSP_dceb7e3e98e176f3cf830482d3460a02 |
---|---|
oai_identifier_str |
oai:repositorio.unesp.br:11449/299532 |
network_acronym_str |
UNSP |
network_name_str |
Repositório Institucional da UNESP |
repository_id_str |
2946 |
spelling |
PLGA/TPGS nanoparticles for docetaxel delivery: The pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cellsDocetaxelPegylationPLGAProstate cancerTPGSProstate cancer is the most common malignancy in men worldwide and docetaxel (DTX) is the treatment of choice. However, both the drug and formulation excipients for drug solubilization can cause side effects. In this context, the development of polymeric nanoparticles offers advantages to improve drug delivery and reduce toxicity. In the present work, factorial design was used to evaluate the effect of the amount of poly(L-lactide-co-glycolide) (PLGA) or poly(L-lactide-co-glycolide acid-polyethylene glycol) (PLGA-PEG), D-Alpha-Tocopheryl Polyethylene Glycol Succinate (TPGS) and ratio between aqueous and oily phases on the nanoparticle characteristics. The nanocarriers were characterized regarding particle size, polydispersity, zeta potential, DTX encapsulation efficiency, morphology by transmission electron microscopy, DSC, TGA and FTIR. It was evaluated in vitro for cytotoxicity and cellular uptake in prostate cancer cells. Pegylated nanoparticles, which have a different composition (TPGS%, AP:OP ratio), reduced the nanoparticle size to 105.97 ± 5.16 nm, in PDI 0.13 ± 0.03, zeta potential of -34.73 ± 1.19 mV and increased the encapsulation efficiency to 96.78 ± 1.20%. Characterization by DSC, TGA and FTIR confirmed drug encapsulation and showed colloidal stability. Pegylated nanoparticles were more stable upon serum incubation and adsorbed less proteins. In conclusion, the pegylation of the nanoparticles affected the physicochemical parameters. Also, the pegylation of nanoparticles decreased uptake by macrophages. Finally, cellular uptake and cell cytotoxicity were higher in tumor cells when compared to non-tumor cells, although they were not affected by pegylation.University of Sao Paulo Faculty of Pharmaceutical Sciences of Ribeirão Preto, SPPaulista State University Faculty of Pharmaceutical Sciences, SPFederal University of Ceará Faculty of Pharmacy Dentistry and Nursing Department of Pharmacy, CEPaulista State University Faculty of Pharmaceutical Sciences, SPUniversidade de São Paulo (USP)Universidade Estadual Paulista (UNESP)Dentistry and NursingSilva, Lívia de Queiróz CarvalhoRaspantini, Giovanni LoureiroAbriata, Juliana PalmaLuiz, Marcela Tavares [UNESP]de Sousa, Ana Carolina CruzMoreira, Thais da SilvaMagalhães, Emanuel Paulade Menezes, Ramon Róseo Paula Pessoa BezerraPetrilli, RaquelMarchetti, Juliana MaldonadoEloy, Josimar O.2025-04-29T18:42:40Z2025-06-01info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1016/j.xphs.2025.103766Journal of Pharmaceutical Sciences, v. 114, n. 6, 2025.1520-60170022-3549https://hdl.handle.net/11449/29953210.1016/j.xphs.2025.1037662-s2.0-105001997005Scopusreponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengJournal of Pharmaceutical Sciencesinfo:eu-repo/semantics/openAccess2025-05-01T05:15:40Zoai:repositorio.unesp.br:11449/299532Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestrepositoriounesp@unesp.bropendoar:29462025-05-01T05:15:40Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false |
dc.title.none.fl_str_mv |
PLGA/TPGS nanoparticles for docetaxel delivery: The pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cells |
title |
PLGA/TPGS nanoparticles for docetaxel delivery: The pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cells |
spellingShingle |
PLGA/TPGS nanoparticles for docetaxel delivery: The pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cells Silva, Lívia de Queiróz Carvalho Docetaxel Pegylation PLGA Prostate cancer TPGS |
title_short |
PLGA/TPGS nanoparticles for docetaxel delivery: The pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cells |
title_full |
PLGA/TPGS nanoparticles for docetaxel delivery: The pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cells |
title_fullStr |
PLGA/TPGS nanoparticles for docetaxel delivery: The pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cells |
title_full_unstemmed |
PLGA/TPGS nanoparticles for docetaxel delivery: The pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cells |
title_sort |
PLGA/TPGS nanoparticles for docetaxel delivery: The pegylation effect on nanoparticle physicochemical properties and uptake and cytotoxicity in prostate cancer cells |
author |
Silva, Lívia de Queiróz Carvalho |
author_facet |
Silva, Lívia de Queiróz Carvalho Raspantini, Giovanni Loureiro Abriata, Juliana Palma Luiz, Marcela Tavares [UNESP] de Sousa, Ana Carolina Cruz Moreira, Thais da Silva Magalhães, Emanuel Paula de Menezes, Ramon Róseo Paula Pessoa Bezerra Petrilli, Raquel Marchetti, Juliana Maldonado Eloy, Josimar O. |
author_role |
author |
author2 |
Raspantini, Giovanni Loureiro Abriata, Juliana Palma Luiz, Marcela Tavares [UNESP] de Sousa, Ana Carolina Cruz Moreira, Thais da Silva Magalhães, Emanuel Paula de Menezes, Ramon Róseo Paula Pessoa Bezerra Petrilli, Raquel Marchetti, Juliana Maldonado Eloy, Josimar O. |
author2_role |
author author author author author author author author author author |
dc.contributor.none.fl_str_mv |
Universidade de São Paulo (USP) Universidade Estadual Paulista (UNESP) Dentistry and Nursing |
dc.contributor.author.fl_str_mv |
Silva, Lívia de Queiróz Carvalho Raspantini, Giovanni Loureiro Abriata, Juliana Palma Luiz, Marcela Tavares [UNESP] de Sousa, Ana Carolina Cruz Moreira, Thais da Silva Magalhães, Emanuel Paula de Menezes, Ramon Róseo Paula Pessoa Bezerra Petrilli, Raquel Marchetti, Juliana Maldonado Eloy, Josimar O. |
dc.subject.por.fl_str_mv |
Docetaxel Pegylation PLGA Prostate cancer TPGS |
topic |
Docetaxel Pegylation PLGA Prostate cancer TPGS |
description |
Prostate cancer is the most common malignancy in men worldwide and docetaxel (DTX) is the treatment of choice. However, both the drug and formulation excipients for drug solubilization can cause side effects. In this context, the development of polymeric nanoparticles offers advantages to improve drug delivery and reduce toxicity. In the present work, factorial design was used to evaluate the effect of the amount of poly(L-lactide-co-glycolide) (PLGA) or poly(L-lactide-co-glycolide acid-polyethylene glycol) (PLGA-PEG), D-Alpha-Tocopheryl Polyethylene Glycol Succinate (TPGS) and ratio between aqueous and oily phases on the nanoparticle characteristics. The nanocarriers were characterized regarding particle size, polydispersity, zeta potential, DTX encapsulation efficiency, morphology by transmission electron microscopy, DSC, TGA and FTIR. It was evaluated in vitro for cytotoxicity and cellular uptake in prostate cancer cells. Pegylated nanoparticles, which have a different composition (TPGS%, AP:OP ratio), reduced the nanoparticle size to 105.97 ± 5.16 nm, in PDI 0.13 ± 0.03, zeta potential of -34.73 ± 1.19 mV and increased the encapsulation efficiency to 96.78 ± 1.20%. Characterization by DSC, TGA and FTIR confirmed drug encapsulation and showed colloidal stability. Pegylated nanoparticles were more stable upon serum incubation and adsorbed less proteins. In conclusion, the pegylation of the nanoparticles affected the physicochemical parameters. Also, the pegylation of nanoparticles decreased uptake by macrophages. Finally, cellular uptake and cell cytotoxicity were higher in tumor cells when compared to non-tumor cells, although they were not affected by pegylation. |
publishDate |
2025 |
dc.date.none.fl_str_mv |
2025-04-29T18:42:40Z 2025-06-01 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://dx.doi.org/10.1016/j.xphs.2025.103766 Journal of Pharmaceutical Sciences, v. 114, n. 6, 2025. 1520-6017 0022-3549 https://hdl.handle.net/11449/299532 10.1016/j.xphs.2025.103766 2-s2.0-105001997005 |
url |
http://dx.doi.org/10.1016/j.xphs.2025.103766 https://hdl.handle.net/11449/299532 |
identifier_str_mv |
Journal of Pharmaceutical Sciences, v. 114, n. 6, 2025. 1520-6017 0022-3549 10.1016/j.xphs.2025.103766 2-s2.0-105001997005 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
Journal of Pharmaceutical Sciences |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
Scopus reponame:Repositório Institucional da UNESP instname:Universidade Estadual Paulista (UNESP) instacron:UNESP |
instname_str |
Universidade Estadual Paulista (UNESP) |
instacron_str |
UNESP |
institution |
UNESP |
reponame_str |
Repositório Institucional da UNESP |
collection |
Repositório Institucional da UNESP |
repository.name.fl_str_mv |
Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP) |
repository.mail.fl_str_mv |
repositoriounesp@unesp.br |
_version_ |
1834482565415698432 |